Reversal of Spinal Cord Damage using Stem Cell Therapy

Click For Summary
SUMMARY

The discussion centers on Hans S. Keirstead's groundbreaking research demonstrating the reversal of spinal cord damage in rats through the use of human embryonic stem cells (hESCs). His study, published in the Journal of Neuroscience in May 2005, shows that transplantation of hESC-derived oligodendrocyte progenitor cells (OPCs) significantly enhances remyelination and improves motor function when administered shortly after injury. Human clinical trials for this therapy may commence as early as next year, bringing hope for individuals paralyzed by spinal cord injuries.

PREREQUISITES
  • Understanding of human embryonic stem cells (hESCs)
  • Knowledge of oligodendrocyte progenitor cells (OPCs)
  • Familiarity with spinal cord injury mechanisms
  • Awareness of clinical trial processes and regulations
NEXT STEPS
  • Research the latest advancements in human embryonic stem cell therapy
  • Explore the role of oligodendrocytes in spinal cord repair
  • Investigate the ethical considerations surrounding stem cell research
  • Learn about the design and implementation of clinical trials in regenerative medicine
USEFUL FOR

Researchers, medical professionals, and anyone interested in advancements in regenerative medicine, particularly those focused on spinal cord injury therapies.

Ouabache
Science Advisor
Homework Helper
Messages
1,349
Reaction score
10
Did anyone happen to catch the 60mins TV spot of Hans S. Keirstead last night?

His research showing reversing spinal cord damage in rats using human embryo stem cells is compelling. Brings this approach to humans paralyzed by spinal cord damage, closer to reality. Human clinical trials may be approved as early as next year.

His findings were published in Journal of Neuroscience last May 2005

Hans S. Keirstead, Gabriel Nistor, Giovanna Bernal, Minodora Totoiu, Frank Cloutier, Kelly Sharp, and Oswald Steward
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury
J. Neurosci., May 2005; 25: 4694 - 4705 ; doi:10.1523/JNEUROSCI.0311-05.2005

Demyelination contributes to loss of function after spinal cord injury, and thus a potential therapeutic strategy involves replacing myelin-forming cells. Here, we show that transplantation of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells (OPCs) into adult rat spinal cord injuries enhances remyelination and promotes improvement of motor function. OPCs were injected 7 d or 10 months after injury. In both cases, transplanted cells survived, redistributed over short distances, and differentiated into oligodendrocytes. Animals that received OPCs 7 d after injury exhibited enhanced remyelination and substantially improved locomotor ability. In contrast, when OPCs were transplanted 10 months after injury, there was no enhanced remyelination or locomotor recovery. These studies document the feasibility of predifferentiating hESCs into functional OPCs and demonstrate their therapeutic potential at early time points after spinal cord injury.
 
Last edited:
Biology news on Phys.org
Yes, I did view the program and it was very interesting.
 
Indeed, I didn't realize we were that close to implementing a therapy that may repair the nerves in the spinal chord and allow para and quadrapalegic individuals a means of acquiring mobility.
 

Similar threads

Replies
4
Views
3K
Replies
1
Views
4K
  • · Replies 2 ·
Replies
2
Views
5K
  • · Replies 13 ·
Replies
13
Views
8K